EC Healthcare announced preliminary unaudited sales results for the period from 1 October 2023 to 31 December 2023. For the quarter, the company's overall sales Volume is 7%+.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 HKD | -1.50% | +5.65% | -24.71% |
Jan. 31 | EC Healthcare Announces Change of Principal Place of Business in Hong Kong, with Effect from 1 February 2024 | CI |
Jan. 24 | EC Healthcare's Overall Sales Volume Rises 7% in Q4 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.71% | 199M | |
-13.39% | 572M | |
+46.75% | 490M | |
+6.68% | 285M | |
-23.87% | 95.07M | |
-3.77% | 80M | |
-20.49% | 64.95M | |
-15.86% | 62.39M | |
-.--% | 61.81M | |
-32.10% | 57.46M |
- Stock Market
- Equities
- 2138 Stock
- News EC Healthcare
- EC Healthcare Announces Preliminary Unaudited Sales Results for the Period from 1 October 2023 to 31 December 2023